2015 Annual Meeting on Women's Cancer®

March 26 - 31, 2015

Catherine M. Behrens, MD, PhD

Director of Clinical Research
Roche Molecular Systems
4300 Hacienda Drive
Pleasanton, CA
USA 94588

Papers:
35 Relative prevalence of high risk HPV genotypes in a US population: insights before rollout of the next generation 9-valent HPV vaccine 36 HPV primary screening incorporating genotyping and p16/Ki-67 dual-stained cytology to determine which HPV positive women would benefit from colposcopy